XNAS
LFWD
Market cap73mUSD
Jun 10, Last price
1.22USD
Name
Rewalk Robotics Ltd
Chart & Performance
P/E
163.46
P/S
2.85
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
135.82%
Rev. gr., 5y
39.41%
Revenues
26m
+85.24%
Net income
448k
P
CFO
-22m
L+5.09%
Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | 25,663 85.24% | 13,854 151.39% | 5,511 -7.63% | ||||||
Cost of revenue | 45,216 | 37,466 | 24,613 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (19,553) | (23,612) | (19,102) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | (29,347) | (12) | 467 | ||||||
Tax Rate | |||||||||
NOPAT | 9,794 | (23,600) | (19,569) | ||||||
Net income | 448 -102.02% | (22,133) 13.10% | (19,569) 53.65% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (992) | (2,500) | |||||||
BB yield | 14.95% | 36.91% | |||||||
| Debt | |||||||||
Debt current | 858 | 1,296 | 564 | ||||||
Long-term debt | 880 | 2,510 | 1,230 | ||||||
Deferred revenue | 1,506 | 890 | |||||||
Other long-term liabilities | 22 | 2,774 | 66 | ||||||
Net debt | (5,008) | (24,986) | (66,761) | ||||||
| Cash flow | |||||||||
Cash from operating activities | (21,718) | (20,667) | (17,891) | ||||||
CAPEX | (81) | (25) | |||||||
Cash from investing activities | (18,149) | (25) | |||||||
Cash from financing activities | (992) | (2,500) | |||||||
FCF | 6,961 | (26,331) | (18,989) | ||||||
| Balance | |||||||||
Cash | 6,746 | 28,083 | 67,896 | ||||||
Long term investments | 709 | 659 | |||||||
Excess cash | 5,463 | 28,099 | 68,279 | ||||||
Stockholders' equity | (263,438) | (231,396) | (209,261) | ||||||
Invested Capital | 284,558 | 284,089 | 279,279 | ||||||
ROIC | 3.44% | ||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 60,044 | 8,531 | 8,911 | ||||||
Price | 1.73 122.45% | 0.78 2.32% | 0.76 -38.20% | ||||||
Market cap | 103,875 1,465.62% | 6,635 -2.05% | 6,773 -19.58% | ||||||
EV | 98,867 | (18,351) | (59,988) | ||||||
EBITDA | (15,712) | (21,765) | (18,900) | ||||||
EV/EBITDA | 0.84 | 3.17 | |||||||
Interest | 128 | 20 | |||||||
Interest/NOPBT | |||||||||